{
    "id": "wrong_mix_random_birth_00065_1",
    "rank": 7,
    "data": {
        "url": "https://www.solventum.com/en-us/home/our-company/leadership",
        "read_more_link": "",
        "language": "en",
        "title": "Leadership: Officers and board of directors",
        "top_image": "https://www.solventum.com/content/dam/public/language-masters/en/entp/image/2024/getty-id-640126767-rt.png",
        "meta_img": "https://www.solventum.com/content/dam/public/language-masters/en/entp/image/2024/getty-id-640126767-rt.png",
        "images": [
            "https://s7d9.scene7.com/is/content/mmmspinco/solventum-logo-horz-black-4?ts=1709949696064&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/getty-id-640126767-rt?ts=1717032976699&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-leadership-portrait-bryan-hanson-env-03-gbl%3AM--large-tablet?ts=1715785624266&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-leadership-portrait-wayde-mcmillan-env-01.gbl%3AM--large-tablet?ts=1715785624434&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-leadership-portrait-arora-sanjiv-left.gbl%3AM--large-tablet?ts=1715785624452&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-leadership-portrait-chris-barry-env-01.gbl%3AM--large-tablet?ts=1715785624471&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-leadership-portrait-tammy-gomez-env-02.gbl%3AM--large-tablet?ts=1715785624547&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-leadership-portrait-paul-harrington-env-03.gbl%3AM--large-tablet?ts=1715785624564&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-leadership-portrait-marcela-kirberger-env-01.gbl%3AM--large-tablet?ts=1715785624582&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-leadership-portrait-amy-landucci-env-02-gbl%3AM--large-tablet?ts=1715785624679&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-leadership-portrait-katie-sagnella-env-02.gbl%3AM--large-tablet?ts=1715785624697&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-leadership-portrait-raymond-chiu-env-02.gbl%3AM--large-tablet?ts=1715785624715&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-leadership-portrait-garri-garrison-env.gbl%3AM--large-tablet?ts=1715785624789&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-leadership-portrait-grannis-vaughn-env-03.gbl%3AM--large-tablet?ts=1715785624806&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-leadership-portrait-karim-mansour-right.gbl%3AM--large-tablet?ts=1715785624824&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-leadership-portrait-mike-spears-env-gbl%3AM--large-tablet?ts=1715785624942&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-bod-portrait-carrie-cox-gbl%3AS--tablet?ts=1715785625101&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-bod-portrait-carlos-alban-gbl%3AM--large-tablet?ts=1715785625285&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-bod-portrait-susan-devore-gbl%3AM--large-tablet?ts=1715785625303&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-bod-portrait-shirley-edwards-gbl%3AM--large-tablet?ts=1715785625320&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-bod-portrait-glenn-eisenberg-gbl%3AM--large-tablet?ts=1715785625393&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-bod-portrait-bernard-harris-gbl%3AM--large-tablet?ts=1715785625411&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-bod-portrait-karen-may-gbl%3AM--large-tablet?ts=1715785625429&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-bod-portrait-elizabeth-mily-gbl%3AM--large-tablet?ts=1715785625523&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-bod-portrait-john-weiland-gbl%3AM--large-tablet?ts=1715785625541&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-bod-portrait-amy-wendell-gbl%3AM--large-tablet?ts=1715785625558&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/entp-solventum-bod-portrait-darryl-wilson-gbl%3AM--large-tablet?ts=1715785625661&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/getty-id-1139013022-rt%3AM--large-tablet?ts=1715785625945&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/shutterstock-id-2321865469-rt%3AM--large-tablet?ts=1715785626066&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/getty-id-1276706590-rt-2800x1200%3AM--large-tablet?ts=1717780895921&dpr=off",
            "https://s7d9.scene7.com/is/image/mmmspinco/getty-id-1316235443-rt%3AM--large-tablet?ts=1715785626105&dpr=off",
            "https://s7d9.scene7.com/is/content/mmmspinco/solventum-logo-horz-white-4?ts=1709949804863&dpr=off"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "Our company"
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2024-05-30T01:36:16.722000",
        "summary": "",
        "meta_description": "Learn about current company officers and board of directors. Includes headshots and links to deeper biographical information.",
        "meta_lang": "en",
        "meta_favicon": "/etc.clientlibs/healthcareweb/clientlibs/clientlib-site/resources/favicon-32x32.png",
        "meta_site_name": "",
        "canonical_link": "https://www.solventum.com/en-us/home/our-company/leadership",
        "text": "Bryan Hanson is CEO of Solventum, an $8.2 billion independent healthcare company rooted in a history of diverse expertise spanning the industry — from medical surgical and dental solutions to health information systems and purification and filtration. He leads 22,000 problem-solving professionals who work tirelessly every day to enable better, smarter, safer healthcare to improve lives and shape the future of health.\n\nPreviously known as 3M Health Care, Solventum has a long legacy of creating breakthrough solutions for our customers’ toughest challenges. By pioneering game-changing innovations at the intersection of health, material, and data science, Solventum is advancing solutions that change patient’s lives for the better — while empowering healthcare professionals to perform at their best. Solventum products and services span the healthcare ecosystem, which makes it uniquely positioned to transform patient experiences, improve outcomes and help reduce total cost of care while driving long-term value for shareholders.\n\nBryan is a visionary leader who is passionate about transformation and building award-winning organizations. Throughout his 33+ year-career he has successfully led, grown, and transformed global medical device businesses at Zimmer Biomet, Medtronic and Covidien to achieve greater innovation and commercial success and drive value for customers, patients and shareholders. He serves on the board of directors of Walgreens Boots Alliance, Inc.\n\nOutside of work, Bryan enjoys spending time with his wife and five children, as well as a variety of fitness activities.\n\nChief Financial Officer\n\nWayde McMillan is known for his finance expertise, deep understanding of the medtech industry and ability to build strong teams. He brings more than 25 years in finance, driving profitable growth in ever-changing environments for leading global and innovative companies. As CFO of Solventum, he is focused on the company’s mission, positioning Solventum for long-term success and creating long-term value for shareholders.\n\nPrior to joining Solventum, Wayde served as Executive Vice President, CFO of innovative medical device company Insulet. He also previously served as CFO and Vice President of Finance of the $8 billion Minimally Invasive Therapies Group at Medtronic and held numerous leadership positions at Covidien from November 2006 until Medtronic’s acquisition of the company in January 2015.\n\nMcMillan started his career in accounting, audit, financial analysis, and investor relations. When not leading the Solventum finance team, he and his wife are learning to appreciate the lifestyle opportunities of empty nesters.\n\nChief Strategy & Corporate Development Officer\n\nSanjiv Arora has more than 35 years of corporate strategy, M&A and investment experience in the medtech and life sciences sectors. As Chief Strategy & Corporate Development Officer, he is responsible for setting the company’s strategic direction, portfolio management and executing inorganic actions to drive our long-term growth strategy.\n\nBefore joining Solventum, Sanjiv was Vice President, Business Development & Strategy, Cardiac Surgery, Cardiovascular Diagnostics at Medtronic, where he has served in a variety of positions over the last six years. His expertise was also honed from working at Edwards LifeSciences, Covidien, Cargill Ventures, RBC Capital Markets and Boston Scientific throughout his career.\n\nSanjiv is an avid endurance athlete who has completed 57 marathons, and lives in Minnesota with his wife, Sanjula, and their dog, Chai.\n\nExecutive Vice President and Group President, Medical Surgical\n\nChris Barry is a pioneering global healthcare and medtech executive who drives success by building high-performing, high-executing teams that continually outperform the industry. As Executive Vice President and Group President of the company’s Medical Surgical business, Chris is laser-focused on strong employee engagement and driving core growth through product and business model innovation and active portfolio management. With over 25 years of med device and technology experience, he has proven how to successfully lead global teams while diversifying organizations with novel acquisitions.\n\nMost recently, Chris was Chief Executive Officer and a member of the NuVasive Board of Directors. Prior to that role, he served as Senior Vice President and President of Surgical Innovations at Medtronic, its second largest business unit. Before the acquisition of Covidien by Medtronic, Chris was President of Advanced Surgical Technologies of Covidien, where he led global strategy, product portfolio, and U.S. commercial teams for the global business unit. He also spent more than 15 years increasing commercial and executive leadership roles at Covidien. Currently, Chris serves as a member of the LivaNova Board of Directors.\n\nChris and his wife, Krista, live in Superior, Colorado. They have four sons – Hunter, Cade, Brayden, and Caysen – and one grandson, Holton.\n\nChief Human Resources Officer\n\nTammy Gomez is passionate about fostering positive work environments and corporate cultures that put people first and are the most preferred places to work. With more than two decades of human resources experience in the healthcare and health services industry, she leads Solventum’s organization-wide policies and programs that attract, support, motivate and develop our team of solvers.\n\nBefore joining Solventum, Tammy was Executive Vice President and Chief Human Resource Officer at Owens & Minor. She also spent more than 20 years at Cardinal Health in various roles of increasing responsibility, including most recently leading its Global HR Center of Excellence & HR Services team. She began her career in finance and worked with Prudential and General Motors.\n\nTammy and her husband share a passion for travel and enjoy spending time with their family and friends.\n\nChief Supply Chain Officer\n\nPaul Harrington is a strategic leader and decisive thinker known for his strong work ethic, global mindset and drive to win. As Chief Supply Chain Officer, Paul oversees Solventum’s plants and distribution centers, while also leading logistics, sourcing, engineering, facilities, real estate and environment, health and safety functions under supply chain.\n\nPaul has extensive global manufacturing, operations and medtech experience. He spent 10 years at Medtronic where he was most recently Senior Vice President, Global Operations Innovation responsible for shaping, transforming and innovating across the global operations and supply chain function. He also previously served as Vice President Global Operations for the Restorative Therapies Group and Neuromodulation business unit. Prior to joining Medtronic, he was Vice President of Global Manufacturing at Covidien.\n\nOriginally from Reading, England, Paul, his wife and two sons are enjoying their adoptive Minnesota lifestyle.\n\nChief Legal Affairs Officer\n\nMarcela Kirberger is an impactful and highly effective global leader known for guiding medtech and life sciences companies through complex business expansion strategies and organizational transformations. As Chief Legal Affairs Officer, she leads the legal, government affairs, global security and ESG teams and is responsible for establishing the strategy for these functions as well as managing the company’s global regulatory compliance and commercial legal and intellectual property matters.\n\nPrior to joining Solventum, Marcela was General Counsel and Corporate Secretary at Elanco, responsible for the global strategy and operations of the legal, government affairs, ESG and ERM areas. Her deep healthcare legal experience also includes U.S., regional and global leadership roles with companies such as Novartis, Roche and Danaher. Prior to joining the Novartis companies in 2006, Marcela was a securities litigator at Lowenstein Sandler in New Jersey.\n\nA native of Argentina, Marcela earned her law degrees from Rutgers School of Law in Newark, New Jersey and the Catholic University of Argentina in Buenos Aires and is currently based in Indianapolis.\n\nChief Information & Digital Officer\n\nAmy Landucci is known for building high-performing teams and has a proven track record of delivering digital and technology transformations within healthcare. As Solventum’s Chief Information & Digital Officer, she works closely with the business and technology leaders to create a world-class digital technology platform that carefully aligns to the company’s overall business strategy enabling global operations to accelerate innovation and growth.\n\nPrior to joining Solventum, Amy was Chief Digital and Technology Officer at Haleon, where she led the technical carveout from GSK to form the world’s largest standalone consumer healthcare company. Prior to GSK, she spent a decade at Novartis in a variety of roles. The first eight years of her career was in consulting with Accenture. Amy has served on the Board of Directors for Healthy Women, the leading independent, non-profit health information source for women in the United States.\n\nIn her free time, she loves to travel, hike and host parties for family and friends.\n\nVice President, Chief of Staff\n\nKatie Sagnella is a highly collaborative, strategic and intrepid leader who loves solving challenges with critical thinking and organization. As Chief of Staff at Solventum, she serves as a trusted advisor to the CEO and engages with senior leaders and stakeholders in the organization to ensure alignment, collaboration, coordination and timely issues resolution with ongoing strategic initiatives across the enterprise.\n\nPrior to joining Solventum, Katie was Senior Director, Corporate Strategy and Executive Communications at Zimmer Biomet. During her more than 15 years in healthcare, she has also held numerous strategy and communications roles at Medtronic and Covidien.\n\nIn her free time, Katie is chasing after her young son, spending time outdoors with her husband or stealing time to read good books whenever possible.\n\nSenior Vice President, Research & Development\n\nRaymond Chiu is a leader with hands-on experience in product commercialization and leading high-performance global teams across multiple industries, geographies, and diverse end-market customers. As head of Research and Development for Solventum, he champions customer insight-driven innovation, advancing technology platforms, and commercialization of new products and solutions that change patients’ lives for the better — while empowering healthcare professionals to perform at their best.\n\nPrior to his current role, Raymond held various positions during his 30-year tenure at 3M, including leading global research and development at 3M’s Divisions in Health Care and Transportation and Electronics. Raymond earned a Ph.D. in Ceramics at Massachusetts Institute of Technology and a dual B.S. in Chemical Engineering and Material Sciences & Engineering from the University of California at Berkeley. He advocates for sustainability, is active in mentoring and championing diversity and inclusion and serves on the Board of the Boys and Girls Club of the Twin Cities.\n\nRaymond resides in the Twin Cities area. He enjoys spending time with his life-long partner Stephanie and two grown-up children. They enjoy the outdoors, travel, and cooking together.\n\nPresident, Health Information Systems\n\nAs a former critical care trauma nurse, Garri Garrison brings unique perspective and passion to her role as President of Solventum’s Health Information Systems (HIS) division. She is responsible for the development of the divisions’ global business strategy, including its product portfolio of innovative technologies that drive efficiency and improve outcomes for everyone, whether they be patients, doctors, nurses, clinical documentation improvement (CDI) specialists or coders.\n\nGarri has more than 35 years of experience in healthcare, including more than 27 years spent at 3M, Solventum’s former parent company. While there she served in a variety of positions for its HIS division, including director of consulting services, director of performance management, integration manager, chief operating officer, Lean Six Master Black Belt and area division leader for the U.S. and Canada.\n\nGarri is a frequent speaker and published author on regulatory issues, quality outcomes, and clinical documentation improvement. Garri is an avid traveler and a huge University of Kentucky basketball fan.\n\nPresident, Purification and Filtration\n\nWith a rich and varied career that includes product development, process engineering, marketing, sales leadership and as a Lean Six Sigma Black Belt, Vaughn Grannis brings a wealth of knowledge and exposure to all aspects of Solventum’s Purification and Filtration business as the President.\n\nFocusing his career on technology enterprises including diversified manufacturers and businesses dealing in high-technology applications and customer groups, Vaughn took the helm of the global P&F business in 2023, leading the business’ four segments: Bioprocessing Filtration, Drinking Water Filtration, Industrial Filtration and Membranes OEM.\n\nVaughn has more than 38 years of experience creating new business growth, profitability and operational performance across several business sectors and verticals, all of which with 3M, Solventum’s former parent company. He holds a master’s degree in mechanical engineering from the University of Minnesota and an MBA from the University of St. Thomas.\n\nVaughn enjoys tennis and outdoor activities like mountain biking and downhill skiing with friends and family.\n\nPresident, Dental Solutions\n\nKarim Mansour is a transformational global leader driven by his relentless passion to deliver better, smarter, safer healthcare to improve lives. As President of Solventum’s Dental Solutions he is focused on reimagining oral care delivery and connecting advanced materials with data science to improve patient outcomes — and transform practices.\n\nKarim leads a large global team in pioneering game-changing innovations at the intersection of health, material, and data science to change patients' lives for the better – while empowering healthcare practitioners to perform at their best. Karim continuously inspires excellence in those around him through his commitment to our promise to never stop solving for customers and leading with a people-first mentality.\n\nWith more than 25 years of international healthcare and medical device experience, Karim has acquired industry expertise within the public and private sectors, academia, as well as healthcare economics. Karim has held leadership roles of increasing responsibility, including his current role as President of Dental Solutions, Senior Vice President of 3M Health Care EMEA, Global Strategy and Business Development Director, as well as global operational and financial leadership roles across Europe, United States and Latin America.\n\nKarim is based in Paris, married with three beautiful children, an avid runner and enjoys jazz music.\n\nSenior Vice President, Regulatory Affairs & Quality Assurance\n\nMike Spears is known for leading organizations that bring innovative products to market, increase customer satisfaction, regulatory compliance, on-time delivery of quality products, and continuous improvements to enhance shareholder value. As Senior Vice President, Regulatory Affairs and Quality Assurance for Solventum, he establishes and delivers quality assurance, regulatory affairs, and compliance strategies, as well as defines and oversees the global quality management system for its worldwide facilities and healthcare-related operations.\n\nMike has more than 30 years of extensive quality assurance, regulatory and compliance experience with major global medical device companies. Prior to joining Solventum, Mike was Senior Vice President, Regulatory Affairs and Compliance, Insulet Corporation where he provided overall leadership, strategy and management for the development and execution of all worldwide regulatory and compliance issues for its product portfolio. He also held Quality Assurance and Regulatory leadership positions and made an impact at Medtronic, Covidien and Tyco Healthcare.\n\nMike and his wife Patty are the proud parents of three sons and enjoy boating, golf, travel and spending time with their golden retriever Ellie.\n\nCarrie S. Cox. Ms. Cox most recently served as the Chief Executive Officer of Humacyte, Inc., a then privately-held regenerative medicine company, between 2010 and 2018; in addition, she served as Chairman of the company’s board between 2013 and 2019, and she remained a member of its board until 2021, prior to its public offering. Ms. Cox served as Executive Vice President of Schering-Plough Corporation and President of Schering-Plough’s global pharmaceutical business between 2003 and 2009, when Schering-Plough merged with Merck. Prior to joining Schering-Plough, Ms. Cox served as President of Pharmacia Corporation’s global pharmaceutical business from 1997 until its merger with Pfizer Inc. in 2003. She currently serves as Chairman of Organon & Co. and Cartesian Therapeutics, Inc. and as a director of Texas Instruments Inc. She served on the Board of Directors of Cardinal Health Inc. from 2009 to 2023, on the Board of Directors of Celgene Corporation from 2009 until its acquisition by Bristol-Myers Squibb Company in 2019, as Chairman of the Board of Directors of electroCore, Inc. between 2018 and 2020, and as Chairman of the Board of Directors of Array BioPharma Inc. from 2018 until its acquisition by Pfizer Inc. in 2019. Ms. Cox is a graduate of the Massachusetts College of Pharmacy and has been named six times to FORTUNE Magazine’s list of the “50 Most Powerful Women in Business.”\n\nFormer Vice Chairman and Chief Commercial Officer, AbbVie, Inc.\n\nCarlos Albán is a seasoned pharmaceutical executive with over 30 years of experience in global commercial strategy and operations. From December 2018 until March 2021, Mr. Albán served as Vice Chairman, Chief Commercial Officer of AbbVie, Inc., responsible for global commercial operations, including the Pharmacyclics commercial functions. From January 2013 until December 2018, he served as AbbVie’s Executive Vice President, Commercial Operations. From February 2011 until December 2012, Mr. Albán served as Senior Vice President, Proprietary Pharmaceutical Products, Global Commercial Operations for Abbott Laboratories, Inc., and previously served at Abbott as Senior Vice President, International Pharmaceuticals from 2009 to 2011, as Vice President, Pharmaceuticals, Western Europe and Canada Operations from 2007 to 2009, as Vice President, Pharmaceuticals, European Operations from 2006 to 2007, as Regional Director for the Northern Europe area of the international pharmaceutical business from 2004 to 2006, and General Manager, Portugal from 2002 to 2004. Mr. Albán currently serves on the board of SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. Mr. Albán received a degree in economics from Pontificia Universidad Javeriana in Bogotá, Colombia.\n\nFormer CEO, Premier Inc.\n\nSusan D. DeVore served as Chief Executive Officer and a member of the Board of Directors of Premier Inc., a leading health care improvement company, from 2013 to May 2021, and also served as President of Premier from 2013 to April 2019. She has served in a consulting capacity for Premier since her retirement in June 2021. Ms. DeVore was President and CEO of a predecessor company, Premier Healthcare Solutions, Inc. from 2009 to 2013 prior to its reorganization, and before that was the Chief Operating Officer for a number of affiliated Premier entities from 2006 to 2009. Prior to joining Premier, Ms. DeVore had two decades of finance, strategy and healthcare consulting experience. Ms. DeVore is also a director of Elevance Health, Inc., serving since August 2021.\n\nEVP and CFO, Laboratory Corporation of America Holdings\n\nGlenn A. Eisenberg has served as Executive Vice President and Chief Financial Officer of Laboratory Corporation of America Holdings, since June 2014. From 2002 until joining the Company, he served as the Executive Vice President of Finance and Administration and Chief Financial Officer at The Timken Company, a leading global manufacturer of highly engineered bearings and alloy steels and related products and services. Previously, he served as President and Chief Operating Officer of United Dominion Industries, a diversified industrial manufacturer, now a subsidiary of SPX Corporation, after working in several roles in finance, including Executive Vice President and Chief Financial Officer. Mr. Eisenberg served on the Board of Directors of US Ecology, Inc. until May 2022, where he chaired the Audit Committee; Family Dollar Stores Inc. until July 2015, where he chaired the Audit Committee; Alpha Natural Resources Inc. until May 2015, where he was the lead independent director and chaired the Nominating and Corporate Governance Committee, and Perspecta Inc. until May 2021, where he served on the Audit Committee. Mr. Eisenberg holds a Bachelor of Arts degree from Tulane University and a Master of Business Administration from Georgia State University.\n\nChief Executive Officer and Managing Partner, Versalius Ventures, Inc.\n\nDr. Bernard A. Harris Jr., is chief executive officer and managing partner of Vesalius Ventures, Inc. He served as a trustee/director for Salient and Barings investment funds. He currently serves on the boards of Raytheon Technologies (NYSE: RTX), U.S. Physical Therapy (NYSE: USPH) and MassMutual. He also served as a board member for the National Academies of Science, Engineering and Medicine - Board on Health Sciences Policy, and is currently on the boards of the Texas Medical Center and the Harris Foundation, which he founded. Dr. Harris is a former NASA astronaut, has logged more than 438 hours and traveled over 7.2 million miles in space. He was a mission specialist on the space shuttle Columbia in 1993 and a payload commander on space shuttle Discovery in 1995, where he became the first African American to walk in space. He earned a Bachelor of Science in Biology from the University of Houston, a Master of Medical Science from the University of Texas Medical Branch at Galveston, a Master of Business Administration from the University of Houston – Clear Lake, and a Doctor of Medicine from Texas Tech University Health Sciences Center School of Medicine. He completed a residency in internal medicine at the Mayo Clinic, a National Research Council Fellowship in endocrinology at the NASA Ames Research Center and trained as a flight surgeon at the United States Air Force School of Aerospace Medicine. He is a fellow of the American College of Physicians, and a member of the American Academy of Arts and Sciences.\n\nFormer EVP and CHRO, Mondelez International, Inc.\n\nKaren J. May, who possesses a unique combination of having been both a financial executive and a human resource executive of global companies, brings to the Board extensive operational, financial and human capital strategy experience. Ms. May has been a member of the board of directors of Ace Hardware Corporation, where she is Chair of the Audit and Finance Committee, since 2017. Since 2019, Ms. May is also a member of the board of directors of Alcon, Inc., where she is chair of the Compensation Committee. Previously, Ms. May was on the board of directors of MB Financial, Inc., where she served as Chair of the Compensation Committee until 2019. From 2012 to 2018, she was the Executive Vice President and Chief Human Resources Officer at Mondelez International, Inc. From 2005 to 2012, Ms. May was the Executive Vice President and Chief Human Resources Officer of Kraft Foods, Inc. Between 1990 and 2005, she held various positions in Human Resources and Finance at Baxter International Inc., including Corporate Vice President and Chief Human Resources Officer, Vice President, International Finance, and Vice President, Division Controller. Prior to Baxter International Inc., Ms. May was a Certified Public Accountant in the audit practice of Price Waterhouse.\n\nFormer EVP, Strategy & Business Development, Bristol-Myers Squibb\n\nElizabeth A. Mily is a 30+ year healthcare and financial industry veteran, serving most recently as the Executive Vice President, Strategy & Business Development, at Bristol-Myers Squibb. In this role, she oversaw the company strategy and approach to sourcing external innovation, including all business development activities, strategic partnerships, alliance management, mergers and acquisitions, and the company’s broad equity investing portfolio. Elizabeth was appointed to the position in March 2020. Prior to joining Bristol-Myers Squibb, Elizabeth was a senior member of the Global Healthcare Group at Barclays where she led its Lifesciences business, including the BioPharma, Life Science Tools and Diagnostics sectors. Prior to joining Barclays, Elizabeth served as Senior Vice President, Corporate Strategy and Development at Thermo Fisher Scientific. Before Thermo Fisher, Elizabeth spent 16 years at Goldman, Sachs & Co., where she was a Managing Director and senior coverage officer within the Healthcare Department of the Investment Banking Division. Elizabeth holds a Master of Science in Foreign Service from Georgetown University and a Bachelor of Arts in German Literature and European History from the Ohio State University. She was also a Fulbright Scholar to the Universities of Cologne and Hamburg, Germany. Prior to attending University, Elizabeth completed a Congress-Bundestag scholarship to Germany. Elizabeth previously served on the Dean’s Advisory Council of the Ohio State University Fisher College of Business and previously served as a Trustee of the Stephen Gaynor School.\n\nFormer President and COO, C.R. Bard, Inc.\n\nJohn H. Weiland served as President and Chief Operating Officer of medical device company C. R. Bard, Inc. from 2003 until 2017, when Bard was acquired by Becton, Dickinson and Company. He also served on Bard’s board of directors from 2005 to 2017, becoming Vice Chairman of the Board in 2016. Mr. Weiland joined Bard in 1996 and held the position of Group President, with global responsibility for several Bard divisions and its worldwide manufacturing operations prior to becoming President and Chief Operating Officer. Prior to Bard, he held senior management positions at Dentsply International, American Hospital Supply, Baxter Healthcare, and Pharmacia AB. Mr. Weiland served on the board of Cardinal Health, Inc. from 2019 to 2022, where he chaired the Risk Oversight Committee. He also brings valuable perspectives and insights from his prior service on the boards of directors of Celgene Corporation, including service on its Audit Committee, and West Pharmaceutical Services’ board of directors, including chairing its Compensation and Finance Committees.\n\nFormer SVP, Strategy and Business Development and Licensing, Covidien\n\nAmy A. Wendell was a Senior Advisor for Perella Weinberg Partner’s Healthcare Investment Banking Practice from 2016 to 2019, providing guidance and advice with respect to mergers and acquisitions and divestures for clients and assisting the firm in connection with firm-level transactions. From 2015 to September 2018, Ms. Wendell served as a Senior Advisor for McKinsey’s Strategy and Corporate Finance Practice and also served as a member of McKinsey’s Transactions Advisory Board to help define trends in mergers and acquisitions, as well as help shape McKinsey’s knowledge agenda. From 1986 until January 2015, Ms. Wendell held various roles of increasing responsibility at Covidien plc (including its predecessors, Tyco Healthcare and Kendall Healthcare Products), including engineering, product management and business development. Most recently, from December 2006 until Covidien’s acquisition by Medtronic plc in January 2015, she served as Senior Vice President of Strategy and Business Development, where she led the company’s strategy and portfolio management initiatives and managed all business development, including acquisitions, equity investments, divestitures and licensing/distribution. Ms. Wendell serves as Lead Director of AxoGen, Inc., where she is a member of the Nominating and Governance Committee and the Audit Committee; at Baxter International, Inc., where she is a member of the Quality, Compliance and Technology Committee and Compensation and Human Capital Committee; and at Hologic, Inc., where she is a member of the Audit and Finance Committee. She also serves on the board of Por Cristo, a non-profit charitable medical service organization involved in health care work for at-risk women and children in Latin America. Ms. Wendell holds a Bachelor of Science in mechanical engineering from Lawrence Technological University and a Master of Science degree in biomedical engineering from the University of Illinois.\n\nFormer Vice President, Commercial, GE Power, General Electric Company\n\nDarryl Wilson is a strategic business executive who has built highly successful organizations and led complex business transformations at General Electric and British Petroleum businesses around the world for more than 35 years. Darryl was a Vice President and Corporate Officer of the General Electric Company. After leaving GE in 2017, Darryl founded The Wilson Collective, an investment and business advisory firm that advises, consults and invests in a portfolio of businesses. He serves on the NextEra Energy Board of Directors, Audit and Compensation Committees and also serves on the Eaton Corporation Board of Directors, Audit and Governance Committees. He was recently appointed to the Primerica Board of Directors. He served as Chairman of the Board of the Dallas Federal Reserve - Houston Branch; Houston Endowment - Finance and Investment Committees; Texas Children's Hospital - Finance and Public Policy Committees; The Kinkaid School Board of Trustees - Finance and Endowment Committees. Darryl also served on the Dallas Federal Reserve Board, Energy Advisory Committee. Darryl held P&L leader roles based internationally in Canada; Budapest, Hungary; London, England and Shanghai, China. He held CEO roles in Asia Pacific, Europe, Middle East and Africa for GE Consumer and Industrial. He served as President & CEO of GE Aero Derivatives Energy, a global aircraft engine technology business and also served as President & CEO GE Consumer Products EMEA. In his final GE position, Darryl was Vice President, Commercial in the GE Power division, leading global sales and marketing for a $38B provider of power generation, transmission, distribution and services. Darryl joined GE in 1992, after earning an MBA in Marketing from Indiana University. He has a BA in Business Administration from Baldwin Wallace College in Ohio and spent the first six years of his career in the Executive Development Program at British Petroleum North America in Cleveland, Ohio. He has been active in many other community organizations; Darryl is a former Board Member and Executive Committee Member of the Greater Houston Partnership, The Houston Food Bank, The American Heart Association, The Dream Foundation, The East End Neighborhood Center and The Greater Cleveland Urban League. Darryl also served on several corporate boards representing General Electric affiliates, and joint ventures internationally. He was appointed by GE and the US Government to the US and Mexico Energy council."
    }
}